Changes in symptoms and fibroid characteristics in women treated with ultrasound‐guided high intensity focused ultrasound ( USgHIFU ) at Chris Hani Baragwanath Academic Hospital
International Journal of Gynecology & Obstetrics · 2025
DOI: 10.1002/ijgo.70742 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, 2025. Verfasst von Raphaela Setzen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics & Gynecology, University of the Witwatersrand, Johannesburg, South Africa. Hauptthemen laut MEDLINE: Leiomyoma, Uterine Neoplasms, High-Intensity Focused Ultrasound Ablation. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective
The main objective was to describe women with fibroids who were treated with ultrasound‐guided high intensity focused ultrasound (USgHIFU) at the Chris Hani Baragwanath Academic Hospital (CHBAH) and to evaluate the outcomes at least 6 months after treatment.
Methods
This was a cross‐sectional study using retrospectively collected data of women treated between November 2015 and December 2018 with USgHIFU at CHBAH. A clinical database that was used at the USgHIFU clinic and medical files were reviewed. The following data were retrieved; demographic information, characteristics of the fibroid (size, number, position, magnetic resonance imaging [MRI] intensity), symptoms before and after the procedure. Variables are described using descriptive statistics and were compared using a McNemar's chi2, t ‐test or Wilcoxon sign rank test.
Results
The mean age, median body mass index (BMI) and median parity was 35 years (standard deviation [SD] ±5.43), BMI of 25.3 (interquartile range [IQR]: 22.31–29.05), parity 0 (IQR: 0–1; range: 0–6), respectively. The presenting symptoms were dysmenorrhea (85.41%), infertility (50.92%) and menorrhagia (67.69%). The proportion of dysmenorrhea decreased from 84.10% before treatment to 54.06% after treatment. Menorrhagia was reduced from 66.08% to 41.34%. The median size of fibroids changed from 38.00 to 26.88 cm 3 . These changes were statistically significant.
Conclusion
This is the first USgHIFU study that reports outcomes in a South African population. The treatment has resulted in a noticeable alleviation of symptoms and a measurable reduction in fibroid size and this was statistically significant and clinically relevant.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics & Gynecology, University of the Witwatersrand, Johannesburg, South Africa.
- Department of Obstetrics & Gynecology, Chris Hani Baragwanath Academic Hospital, Johannesburg, Gauteng, South Africa.
ORCID-Profile: Yasmin Adam
Zitieren
APA
Setzen, R., Setzen, R., O'Donoghue, C., Van Dyk, N., Sengane, A., Manyatsi, N., Sarubdeo, S., & Adam, Y. (2025). Changes in symptoms and fibroid characteristics in women treated with ultrasound‐guided high intensity focused ultrasound ( USgHIFU ) at Chris Hani Baragwanath Academic Hospital. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.70742
Vancouver
Setzen R, Setzen R, O'Donoghue C, Van Dyk N, Sengane A, Manyatsi N, et al. Changes in symptoms and fibroid characteristics in women treated with ultrasound‐guided high intensity focused ultrasound ( USgHIFU ) at Chris Hani Baragwanath Academic Hospital. International Journal of Gynecology & Obstetrics. 2025. doi:10.1002/ijgo.70742
BibTeX
@article{Setzen2025,
author = {Setzen, Raphaela and Setzen, Raymond and O'Donoghue, Claire and Van Dyk, Nico and Sengane, Ayanda and Manyatsi, Nomvuyo and Sarubdeo, Shalya and Adam, Yasmin},
title = {Changes in symptoms and fibroid characteristics in women treated with ultrasound‐guided high intensity focused ultrasound ( USgHIFU ) at Chris Hani Baragwanath Academic Hospital},
journal = {International Journal of Gynecology & Obstetrics},
year = {2025},
doi = {10.1002/ijgo.70742}
}
EUVIMED